Skip to main content

FDA Approvals

Breast Cancer, FDA Approvals, Oncology
Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
Read More
FDA Approvals, In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
FDA Approvals, In the News
Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors
Read More
FDA Approvals
Atezolizumab First PD-L1 Inhibitor Approved by the FDA for Advanced or Metastatic Urothelial Cancer
Lilly Ostrovsky
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
FDA Approvals, In the News
FDA Approves Infliximab Biosimilar for Multiple Indications
Read More
FDA Approvals, In the News
FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow
Read More
Page 17 of 21
Results 161 - 170 of 202